U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584720) titled 'Study of Midomafetamine in Healthy Adults' on April 30. Brief Summary: This Phase 1 study i... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583290) titled 'Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB' on March... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584954) titled 'Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Toleranc... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584811) titled 'Efficacy and Safety of Overnight Occlusive HA35 Gel for Facial Aesthetic Improvement' on Apr... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07582627) titled 'Acceptance and Commitment Therapy for Parents of Children With ASD: Effects on Cognitive Fus... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585487) titled 'Paracetamol and Cefazolin Pharmacokinetics in Normal Weight and Overweight Children' on Jan.... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585513) titled 'Beta-3 Enhanced Autonomic Therapy for POTS' on April 30. Brief Summary: The study will test... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583186) titled 'Maternal Intake of Eggs and Infant Neurodevelopment' on April 30. Brief Summary: The fetal ... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583316) titled 'A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, ... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585136) titled 'Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders' on April 16. Bri... Read More